Showing results (81-90 of 302) with videos related to
Sort By:
Pageof 31
Atherosclerosis|December 25, 2010
High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patientsSophie Liabeuf, Daniela V Barreto, Axel Kretschmer, et al.Nephrologie & Therapeutique|March 4, 2022
[Prevalence of iron deficiency in patients with non-dialysis chronic kidney disease: The CARENFER national, multicentre, observational study]Gabriel Choukroun, Isabelle Kazes, Jacques Dantal, et al.BMC Musculoskeletal Disorders|July 4, 2025
Vacuolar myopathy associated with lambda light chain myeloma: a case report and review of the literatureQuentin de Berny, Valéry Salle, Cédric Renard, et al.Kidney International Reports|January 11, 2021
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal TransplantationJustine Marienne, Solène M Laville, Pauline Caillard, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 30, 2021
Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitorsCamille André, Gabriel Choukroun, Youssef Bennis, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 23, 2010
The phase angle and mass body cell as markers of nutritional status in hemodialysis patientsClaudia M C Oliveira, Marcos Kubrusly, Rosa S Mota, et al.Clinical Kidney Journal|January 9, 2025
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trialMaxime Pluquet, Solène M Laville, François Brazier, et al.Toxins|September 25, 2019
New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney DiseaseLucie Hénaut, Alexandre Candellier, Cédric Boudot, et al.Nature Clinical Practice. Nephrology|August 26, 2006
Drug Insight: renal indications of calcimimeticsIrina Shahapuni, Matthieu Monge, Roxana Oprisiu, et al.Plos One|July 5, 2013
Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?Sophie Liabeuf, Griet Glorieux, Aurelie Lenglet, et al.Pageof 31